Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.46B |
| 2 |
Apple
AAPL
|
+$931M |
| 3 |
Tesla
TSLA
|
+$793M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$769M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$644M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$703M |
| 2 |
Bank of America
BAC
|
+$690M |
| 3 |
Amazon
AMZN
|
+$678M |
| 4 |
JPMorgan Chase
JPM
|
+$601M |
| 5 |
Meta Platforms (Facebook)
META
|
+$431M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 92.11% |
| 2 | Technology | 2.38% |
| 3 | Consumer Discretionary | 1.48% |
| 4 | Healthcare | 0.92% |
| 5 | Communication Services | 0.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3851
CALL
Lear
LEA
$8.26B
| $3.8M | ﹤0.01% |
23,900
-7,000
| -23% | -$985K |
|
|
CTRA
3852
CALL
DELISTED
Coterra Energy
CTRA
| $3.8M | ﹤0.01% |
233,400
+12,800
| +6% | +$225K |
|
3853
Madrigal Pharmaceuticals
MDGL
$12.3B
| $3.8M | ﹤0.01% |
34,170
-17,756
| -34% | -$2.17M |
|
3854
PUT
Invesco S&P 500 Low Volatility ETF
SPLV
$7.03B
| $3.8M | ﹤0.01% |
67,500
+14,600
| +28% | +$802K |
|
3855
PUT
Blackstone Mortgage Trust
BXMT
$2.31B
| $3.79M | ﹤0.01% |
137,700
-21,200
| -13% | -$535K |
|
3856
CALL
iShares MSCI Taiwan ETF
EWT
$11.7B
| $3.79M | ﹤0.01% |
71,400
-77,000
| -52% | -$3.76M |
|
|
WCC
3857
CALL
WESCO International
WCC
$16.4B
| $3.78M | ﹤0.01% |
48,200
-2,900
| -6% | -$172K |
|
|
GTHX
3858
PUT
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $3.78M | ﹤0.01% |
210,300
+182,200
| +648% | +$2.72M |
|
|
PLLL
3859
PUT
DELISTED
Piedmont Lithium Limited American Depositary Receipts
PLLL
| $3.78M | ﹤0.01% |
+142,500
| New | +$3.78M |
|
3860
Global X Cybersecurity ETF
BUG
$1.64B
| $3.78M | ﹤0.01% |
133,930
+49,354
| +58% | +$1.15M |
|
3861
United Therapeutics
UTHR
$22.1B
| $3.78M | ﹤0.01% |
24,909
+15,992
| +179% | +$2.1M |
|
3862
CALL
Bank of Hawaii
BOH
$3.05B
| $3.78M | ﹤0.01% |
49,300
+26,900
| +120% | +$1.84M |
|
3863
PUT
WD-40
WDFC
$2.91B
| $3.77M | ﹤0.01% |
14,200
-48,300
| -77% | -$11.7M |
|
3864
CALL
Packaging Corp of America
PKG
$21.4B
| $3.77M | ﹤0.01% |
27,300
-88,600
| -76% | -$11.2M |
|
3865
ProShares UltraPro Short QQQ
SQQQ
$1.82B
| $3.76M | ﹤0.01% |
1,983
-3,377
| -63% | -$8.18M |
|
|
DCP
3866
CALL
DELISTED
DCP Midstream, LP
DCP
| $3.76M | ﹤0.01% |
203,200
+38,200
| +23% | +$600K |
|
|
NGA
3867
DELISTED
Northern Genesis Acquisition Corp.
NGA
| $3.76M | ﹤0.01% |
+211,657
| New | +$2.59M |
|
3868
VanEck Biotech ETF
BBH
$460M
| $3.76M | ﹤0.01% |
22,181
+12,362
| +126% | +$2.04M |
|
|
SRG
3869
Seritage Growth Properties
SRG
$119M
| $3.76M | ﹤0.01% |
256,148
+58,015
| +29% | +$858K |
|
3870
PUT
Acadia Healthcare
ACHC
$2.66B
| $3.75M | ﹤0.01% |
74,600
+64,000
| +604% | +$2.55M |
|
3871
CALL
Cardiff Oncology
CRDF
$73.1M
| $3.75M | ﹤0.01% |
208,400
-54,200
| -21% | -$953K |
|
|
AGNT
3872
PUT
AGNT Inc
AGNT
$709M
| $3.75M | ﹤0.01% |
118,800
+28,000
| +31% | +$773K |
|
|
JNPR
3873
DELISTED
Juniper Networks
JNPR
| $3.75M | ﹤0.01% |
166,462
+76,203
| +84% | +$1.66M |
|
3874
PUT
Vanguard Energy ETF
VDE
$10.7B
| $3.75M | ﹤0.01% |
71,600
+22,600
| +46% | +$1.06M |
|
3875
Itron
ITRI
$4.27B
| $3.74M | ﹤0.01% |
38,999
+19,343
| +98% | +$1.49M |
|
Similar funds
Jeff Yass's Q4 2020 Portfolio in Review
As of Q4 2020, Jeff Yass held 12,204 positions worth $612B, up 17% from $522B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Jeff Yass's Q4 2020 filing shows 1,722 new, 4,580 increased, 4,534 reduced and 1,264 closed positions. Its largest new stake was International Flavors & Fragrances: 726,729 shares worth $79.1M. The largest sale was Citigroup, an estimated $703M.
By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, down from 93% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q4 2020 buy was International Flavors & Fragrances: 726,729 shares worth $79.1M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $1.46B increase.
- Jeff Yass's biggest Q4 2020 reduction was Citigroup, cutting an estimated $703M.
- Jeff Yass fully exited Vanguard Total International Bond ETF in Q4 2020, selling an estimated $146M.
- Jeff Yass's ten largest holdings make up 32% of its $612B portfolio in Q4 2020.
- Jeff Yass opened 1,722 new positions and closed 1,264 in Q4 2020.
- Jeff Yass's portfolio value rose 17% quarter-over-quarter to $612B.
Based on Susquehanna International Group's 13F filing for Q4 2020, filed 16 Feb 2021.